Christoph Gorgulla

Oct 26, 2023 | nature.com | Christoph Gorgulla |Sara Marchese |Sergio Valente |Thibault Viennet |Melissa Ronan |Matthew Rees | +5 more

AbstractNADPH oxidases (NOXs) are transmembrane enzymes that are devoted to the production of reactive oxygen species (ROS). In cancers, dysregulation of NOX enzymes affects ROS production, leading to redox unbalance and tumor progression. Consequently, NOXs are a drug target for cancer therapeutics, although current therapies have off-target effects: there is a need for isoenzyme-selective inhibitors.

May 23, 2023 | pubmed.ncbi.nlm.nih.gov | Christoph Gorgulla

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software